217 related articles for article (PubMed ID: 11801669)
21. Memory Th2 effector cells can develop in the absence of B7-1/B7-2, CD28 interactions, and effector Th cells after priming with an intestinal nematode parasite.
Ekkens MJ; Liu Z; Liu Q; Foster A; Whitmire J; Pesce J; Sharpe AH; Urban JF; Gause WC
J Immunol; 2002 Jun; 168(12):6344-51. PubMed ID: 12055251
[TBL] [Abstract][Full Text] [Related]
22. A role for inducible costimulator protein in the CD28- independent mechanism of resistance to Toxoplasma gondii.
Villegas EN; Lieberman LA; Mason N; Blass SL; Zediak VP; Peach R; Horan T; Yoshinaga S; Hunter CA
J Immunol; 2002 Jul; 169(2):937-43. PubMed ID: 12097399
[TBL] [Abstract][Full Text] [Related]
23. Deletion of IL-4Ralpha on CD4 T cells renders BALB/c mice resistant to Leishmania major infection.
Radwanska M; Cutler AJ; Hoving JC; Magez S; Holscher C; Bohms A; Arendse B; Kirsch R; Hunig T; Alexander J; Kaye P; Brombacher F
PLoS Pathog; 2007 May; 3(5):e68. PubMed ID: 17500591
[TBL] [Abstract][Full Text] [Related]
24. Distinct immunological states in murine cutaneous leishmaniasis by immunising with different amounts of antigen: the generation of beneficial, potentially harmful, harmful and potentially extremely harmful states.
Bretscher PA; Ogunremi O; Menon JN
Behring Inst Mitt; 1997 Feb; (98):153-9. PubMed ID: 9382736
[TBL] [Abstract][Full Text] [Related]
25. Interleukin-4-independent acceleration of cutaneous leishmaniasis in susceptible BALB/c mice following treatment with anti-CTLA4 antibody.
Heinzel FP; Maier RA
Infect Immun; 1999 Dec; 67(12):6454-60. PubMed ID: 10569763
[TBL] [Abstract][Full Text] [Related]
26. The potency and durability of DNA- and protein-based vaccines against Leishmania major evaluated using low-dose, intradermal challenge.
Méndez S; Gurunathan S; Kamhawi S; Belkaid Y; Moga MA; Skeiky YA; Campos-Neto A; Reed S; Seder RA; Sacks D
J Immunol; 2001 Apr; 166(8):5122-8. PubMed ID: 11290794
[TBL] [Abstract][Full Text] [Related]
27. The IL-4 rapidly produced in BALB/c mice after infection with Leishmania major down-regulates IL-12 receptor beta 2-chain expression on CD4+ T cells resulting in a state of unresponsiveness to IL-12.
Himmelrich H; Parra-Lopez C; Tacchini-Cottier F; Louis JA; Launois P
J Immunol; 1998 Dec; 161(11):6156-63. PubMed ID: 9834101
[TBL] [Abstract][Full Text] [Related]
28. In BALB/c mice, IL-4 production during the initial phase of infection with Leishmania major is necessary and sufficient to instruct Th2 cell development resulting in progressive disease.
Himmelrich H; Launois P; Maillard I; Biedermann T; Tacchini-Cottier F; Locksley RM; Röcken M; Louis JA
J Immunol; 2000 May; 164(9):4819-25. PubMed ID: 10779790
[TBL] [Abstract][Full Text] [Related]
29. Characterization of the immunological memory state generated in mice susceptible to Leishmania major following exposure to low doses of L. major and resulting in resistance to a normally pathogenic challenge.
Menon JN; Bretscher PA
Eur J Immunol; 1996 Jan; 26(1):243-9. PubMed ID: 8566074
[TBL] [Abstract][Full Text] [Related]
30. Leishmania major-infected murine langerhans cell-like dendritic cells from susceptible mice release IL-12 after infection and vaccinate against experimental cutaneous Leishmaniasis.
von Stebut E; Belkaid Y; Nguyen BV; Cushing M; Sacks DL; Udey MC
Eur J Immunol; 2000 Dec; 30(12):3498-506. PubMed ID: 11093169
[TBL] [Abstract][Full Text] [Related]
31. Setting in motion the immune mechanisms underlying genetically determined resistance and susceptibility to infection with Leishmania major.
Launois P; Conceiçao-Silva F; Himmerlich H; Parra-Lopez C; Tacchini-Cottier F; Louis JA
Parasite Immunol; 1998 May; 20(5):223-30. PubMed ID: 9651923
[TBL] [Abstract][Full Text] [Related]
32. A single intramuscular injection with an adenovirus-expressing IL-12 protects BALB/c mice against Leishmania major infection, while treatment with an IL-4-expressing vector increases disease susceptibility in B10.D2 mice.
Gabaglia CR; Pedersen B; Hitt M; Burdin N; Sercarz EE; Graham FL; Gauldie J; Braciak TA
J Immunol; 1999 Jan; 162(2):753-60. PubMed ID: 9916695
[TBL] [Abstract][Full Text] [Related]
33. The early IL-4 response to Leishmania major and the resulting Th2 cell maturation steering progressive disease in BALB/c mice are subject to the control of regulatory CD4+CD25+ T cells.
Aseffa A; Gumy A; Launois P; MacDonald HR; Louis JA; Tacchini-Cottier F
J Immunol; 2002 Sep; 169(6):3232-41. PubMed ID: 12218142
[TBL] [Abstract][Full Text] [Related]
34. Genetic background influences immune responses and disease outcome of cutaneous L. mexicana infection in mice.
Rosas LE; Keiser T; Barbi J; Satoskar AA; Septer A; Kaczmarek J; Lezama-Davila CM; Satoskar AR
Int Immunol; 2005 Oct; 17(10):1347-57. PubMed ID: 16141242
[TBL] [Abstract][Full Text] [Related]
35. Site-specific immunity to Leishmania major in SWR mice: the site of infection influences susceptibility and expression of the antileishmanial immune response.
Nabors GS; Farrell JP
Infect Immun; 1994 Sep; 62(9):3655-62. PubMed ID: 8063382
[TBL] [Abstract][Full Text] [Related]
36. Dectin-1 Positive Dendritic Cells Expand after Infection with
Zimara N; Chanyalew M; Aseffa A; van Zandbergen G; Lepenies B; Schmid M; Weiss R; Rascle A; Wege AK; Jantsch J; Schatz V; Brown GD; Ritter U
Front Immunol; 2018; 9():263. PubMed ID: 29535708
[TBL] [Abstract][Full Text] [Related]
37. Transgenic expression of CXCR3 on T cells enhances susceptibility to cutaneous Leishmania major infection by inhibiting monocyte maturation and promoting a Th2 response.
Oghumu S; Stock JC; Varikuti S; Dong R; Terrazas C; Edwards JA; Rappleye CA; Holovatyk A; Sharpe A; Satoskar AR
Infect Immun; 2015 Jan; 83(1):67-76. PubMed ID: 25312956
[TBL] [Abstract][Full Text] [Related]
38. Toll-like receptor 2 (TLR2) plays a role in controlling cutaneous leishmaniasis in vivo, but does not require activation by parasite lipophosphoglycan.
Halliday A; Bates PA; Chance ML; Taylor MJ
Parasit Vectors; 2016 Oct; 9(1):532. PubMed ID: 27716391
[TBL] [Abstract][Full Text] [Related]
39. Leishmania promastigotes evade interleukin 12 (IL-12) induction by macrophages and stimulate a broad range of cytokines from CD4+ T cells during initiation of infection.
Reiner SL; Zheng S; Wang ZE; Stowring L; Locksley RM
J Exp Med; 1994 Feb; 179(2):447-56. PubMed ID: 7905017
[TBL] [Abstract][Full Text] [Related]
40. IL-4-deficient Balb/c mice resist infection with Leishmania major.
Kopf M; Brombacher F; Köhler G; Kienzle G; Widmann KH; Lefrang K; Humborg C; Ledermann B; Solbach W
J Exp Med; 1996 Sep; 184(3):1127-36. PubMed ID: 9064329
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
